RT Journal Article
SR Electronic
T1 Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 83
DO 10.1186/s40425-017-0290-x
VO 5
IS 1
A1 Jamal, Rahima
A1 Lapointe, Réjean
A1 Cocolakis, Eftihia
A1 Thébault, Paméla
A1 Kazemi, Shirin
A1 Friedmann, Jennifer E.
A1 Dionne, Jeanne
A1 Cailhier, Jean-François
A1 Bélanger, Karl
A1 Ayoub, Jean-Pierre
A1 Le, Huy
A1 Lambert, Caroline
A1 El-Hajjar, Jida
A1 van Kempen, Léon C.
A1 Spatz, Alan
A1 Miller, Wilson H.
YR 2017
UL http://jitc.bmj.com/content/5/1/83.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.